On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Damon Bass

ResearcherPublications, citations & collaboration network

Damon Bass is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Damon Bass have?

ScholarIQindexed works

Damon Bass has 38 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Damon Bass have?

ScholarIQcitation count

Damon Bass has 2,342 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Damon Bass?

ScholarIQh-index

Damon Bass has an h-index of 19 in OpenAlex.

What is the i10-index of Damon Bass?

ScholarIQi10-index

Damon Bass has an i10-index of 25 in OpenAlex.

What is the ORCID of Damon Bass?

ScholarIQorcid

The ORCID for Damon Bass is on the source record.

What is the OpenAlex record for Damon Bass?

ScholarIQopenalex

The OpenAlex for Damon Bass is on the source record.

What are the most-cited papers on Damon Bass?

ScholarIQmost cited works
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study
William Stohl, Andreas Schwarting, Masato Okada, Morton Scheinberg, Andrea Doria, Anne E. Hammer, C. Kleoudis, James Groark, Damon Bass, Norma Lynn Fox, David A. Roth, David Gordon
Arthritis & Rheumatology. 2017422 CitationsOPEN ACCESS
A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
Fengchun Zhang, Sang‐Cheol Bae, Damon Bass, Myron Chu, Sally Egginton, David Gordon, David A. Roth, Jie Zheng, Yoshiya Tanaka
Annals of the Rheumatic Diseases. 2018297 CitationsOPEN ACCESS
Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review
Evelyn Sarnes, Leslie J. Crofford, Maria Watson, Greg Dennis, Hong Kan, Damon Bass
Clinical Therapeutics. 2011261 CitationsOPEN ACCESS
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression
Anadi Mahajan, Justyna Amelio, Kerry Gairy, Gavneet Kaur, Roger A. Levy, David A. Roth, Damon Bass
Lupus. 2020208 CitationsOPEN ACCESS
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis
Brad H. Rovin, Richard Furie, Y K Onno Teng, Gabriel Contreras, Ana Malvar, Xueqing Yu, Beulah Ji, Yulia Green, Tania Gonzalez‐Rivera, Damon Bass, Jennifer Gilbride, Chun-Hang Tang, David A. Roth
Kidney International. 2021207 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial